نتایج جستجو برای: metabolic inhibitors

تعداد نتایج: 400066  

2011
Xiangdong Su Fabienne Pradaux-Caggiano Nigel Vicker Mark P Thomas Heather Halem Michael D Culler Barry V L Potter

Elevated levels of active glucocorticoids have been implicated in the development of several phenotypes of metabolic syndrome, such as type 2 diabetes and obesity. 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) catalyses the intracellular conversion of inactive cortisone to cortisol. Selective 11β-HSD1 inhibitors have shown beneficial effects in various conditions, including diabetes, dysli...

Journal: :The Journal of pharmacology and experimental therapeutics 2000
K Yamano K Yamamoto H Kotaki S Takedomi H Matsuo Y Sawada T Iga

To evaluate the degree of drug-drug interaction concerning metabolic inhibition in the liver quantitatively, we tried to predict the plasma concentration increasing ratio (R) of midazolam (MDZ) by erythromycin (EM), diltiazem (DLZ), or verapamil (VER) in rats. MDZ was administered through the portal vein at the steady state of plasma concentration of these inhibitors. The R values in the area u...

Journal: :Biochimica et biophysica acta 2016
Kalavathi Dasuri Jennifer K Pepping Sun-Ok Fernandez-Kim Sunita Gupta Jeffrey N Keller Philipp E Scherer Annadora J Bruce-Keller

HIV protease inhibitors are key components of HIV antiretroviral therapies, which are fundamental in the treatment of HIV infection. However, the protease inhibitors are well-known to induce metabolic dysfunction which can in turn escalate the complications of HIV, including HIV associated neurocognitive disorders. As experimental and epidemiological data support a therapeutic role for adiponec...

2000

More than 60 human immunodeficiency virus protease inhibitors were examined for the structure-activity relationship between metabolic stability, CYP3A4 inhibitory potency, and substrate-induced binding spectra with a ferric form of P450 in human liver microsomes. A positive relationship was found between CYP3A4 inhibitory potency and metabolic stability; namely, compounds that were more potent ...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2001
M Chiba L Jin W Neway J P Vacca J R Tata K Chapman J H Lin

More than 60 human immunodeficiency virus protease inhibitors were examined for the structure-activity relationship between metabolic stability, CYP3A4 inhibitory potency, and substrate-induced binding spectra with a ferric form of P450 in human liver microsomes. A positive relationship was found between CYP3A4 inhibitory potency and metabolic stability; namely, compounds that were more potent ...

2010
G Orlando

Background The decreased mortality rate obtained with antiretrovirals (ARVs) induced a shift of HIV infection toward a chronic condition and increased the fraction of patients aged >50years. Senior patients can be included in three subgroups with different clinical problems. Long term exposure to ARVs give rise to the main clinical problems. Several studies recognize age as an independent risk ...

Journal: :Bioorganic & medicinal chemistry letters 2009
Takeo Kasagami In-Hae Kim Hsing-Ju Tsai Kosuke Nishi Bruce D Hammock Christophe Morisseau

We investigated N-adamantyl-N'-phenyl urea derivatives as simple sEH inhibitors. Salicylate ester derivatives have high inhibitory activities against human sEH, while the free benzoic acids are less active. The methyl salicylate derivative is a potent sEH inhibitor, which also has high metabolic and chemical stabilities; suggesting that such inhibitors are potential lead molecule for bioactive ...

2000

More than 60 human immunodeficiency virus protease inhibitors were examined for the structure-activity relationship between metabolic stability, CYP3A4 inhibitory potency, and substrate-induced binding spectra with a ferric form of P450 in human liver microsomes. A positive relationship was found between CYP3A4 inhibitory potency and metabolic stability; namely, compounds that were more potent ...

Journal: :Oncology 2010
Amanda J Redig Hidayatullah G Munshi

The incidence of metabolic syndrome is rapidly increasing. Metabolic syndrome is associated with elevated morbidity and mortality secondary to cardiovascular disease, insulin resistance, and hepatic dysfunction. A body of evidence has already implicated metabolic syndrome as a cancer risk factor; emerging evidence now suggests that cancer survivors themselves may be at risk for developing metab...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید